Pharmacy drugs
Ended Awarded Last action
- Contract number
- 36C26024F0040
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $193,220
Award facts
- Contract value 54% obligated
- $356,183.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Horsham, PA 19044, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$52,929 | |
| Other Administrative Action | $41,593 | |
| Original award | $204,556 |
About this award
This federal contract award to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., is for the supply of PHARMACY DRUGS, specifically oncology medications and other specialty drugs, to the U.S. Department of Veterans Affairs (VA). The $356,183.07 ceiling value contract was awarded on October 1, 2023 and has an ultimate completion date of September 30, 2024. This contract is a Delivery Order issued under Janssen Biotech's $3.1 billion multiple-award Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) with the VA, which was awarded in September 2019. The contract does not have a set-aside designation, as Janssen Biotech is a large, for-profit pharmaceutical manufacturer. The primary products being supplied under this contract are BALVERSA (erdafitinib), a cancer treatment drug, as well as WELIREG (belzutifan), another oncology medication. These critical drugs are being provided to various Veterans Integrated Service Networks (VISNs) within the VA's Veterans Health Administration (VHA) to support healthcare services for veterans across the country.
Quick answers
Who was awarded contract 36C26024F0040?
36C26024F0040 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2023.
How much is contract 36C26024F0040 worth?
The government has obligated $193,220 on 36C26024F0040. Its current value, with exercised options, is $356,183.
Is contract 36C26024F0040 an order under another contract?
Yes. 36C26024F0040 is a delivery order under 36F79719D0217, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0040 competed?
The extent of competition for 36C26024F0040 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award